Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC) Meeting Abstract
| Authors: | Ravaud, A.; Motzer, R. J.; Pandha, H. S.; Staehler, M.; George, D.; Pantuck, A. J.; Patel, A.; Chang, Y. H.; Escudier, B.; Donskov, F.; Magheli, A.; Carteni, G.; Laguerre, B.; Tomczak, P.; Breza, J.; Gerletti, P.; Lin, X.; Lechuga, M.; Martini, J. F.; Patard, J. J. |
| Abstract Title: | Phase III trial of sunitinib (SU) vs placebo (PBO) as adjuvant treatment for high-risk renal cell carcinoma (RCC) after nephrectomy (S-TRAC) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi565 |
| Language: | English |
| ACCESSION: | WOS:000393913000711 |
| DOI: | 10.1093/annonc/mdw435.22 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA11_PR -- Source: Wos |
